Compounded Semaglutide Shelf Life After Opening | PlexusDx

Compounded semaglutide typically remains stable and safe for 28 days after initial use when properly refrigerated at 2–8°C (36–46°F). This timeframe applies to single-use or multi-dose vials from licensed 503A compounding pharmacies, which compound medications under strict USP standards to match pharmaceutical-grade quality.

Knowing your medication's shelf life after opening is critical for maintaining consistent treatment and avoiding gaps in your therapy. PlexusDx prioritizes patient education on medication stewardship so you can take an active role in your care while working with your provider to optimize your dosing schedule.

Understanding Compounded Semaglutide Stability Post-Opening

Once opened, compounded semaglutide remains chemically stable for up to 28 days under refrigeration. This stability window is based on pharmaceutical testing protocols that verify potency, purity, and sterility throughout the storage period. Different compounding pharmacies may provide slightly different expiration timeframes based on their formulation.

Temperature consistency matters significantly. Leaving your semaglutide at room temperature or exposing it to heat degrades the peptide structure, reducing efficacy and potentially creating safety concerns. A dedicated medication compartment in your refrigerator—away from the back where it's coldest—helps maintain optimal conditions.

Compounded vs. Branded Semaglutide: Storage and Stability Comparison

Compounded semaglutide from licensed 503A pharmacies follows USP standards for stability and potency verification. Understanding how your specific formulation compares to other options helps you make informed decisions with your provider about which product best fits your lifestyle and treatment goals.

The table below outlines key differences in post-opening shelf life, storage requirements, and clinical considerations across common semaglutide delivery options.

Best Practices for Tracking and Using Your Open Vial

Label your vial with the opening date using a waterproof marker as soon as you first use it. Many patients benefit from setting phone reminders at day 25 to alert them that their current vial expires in 3 days, ensuring they have a refill ready before running out. This prevents treatment gaps.

Never reuse a vial past its 28-day window, even if it appears clear and unchanged. Visual appearance doesn't indicate chemical integrity or sterility. Discard expired compounded medication according to pharmacy guidelines or local pharmaceutical disposal programs, and contact your provider immediately to obtain a fresh supply.

Medical Considerations and When to Involve Your Provider

Your treatment plan should align with your vial's open-date timeline. If you inject multiple times weekly, your 28-day supply depletes faster than if you dose once weekly. A qualified provider can adjust your prescription frequency and vial size to match your injection schedule and minimize waste or gaps.

Certain genetic predispositions in peptide pathways—detectable through the Precision Peptide Genetic Test—may influence how quickly you reach therapeutic response, which can inform dosing timing and vial-use planning. Always discuss medication stability and refill logistics during your initial and follow-up consultations.

How PlexusDx Supports a More Personalized Approach

Understanding your compounded semaglutide's post-opening stability window may help provide context for treatment planning and medication stewardship. PlexusDx partners with licensed 503A compounding pharmacies that follow USP standards, meaning your compounded semaglutide undergoes rigorous stability and potency verification. This precision approach supports consistent dosing and clinical outcomes.

The Precision Peptide Genetic Test reveals genetic predispositions in peptide pathways (including GIPR rs1800437, GLP1R rs6923761, and MC4R rs17782313) that may influence how your body metabolizes GLP-1 medications. While genetics does not predict exact medication response, understanding your peptide genetic profile can support a more informed conversation with your provider about treatment timing, dosing adjustments, and medication continuity planning.

When you combine knowledge of your vial's 28-day shelf life with personalized peptide genetic context, you and your provider can make more strategic decisions about prescription intervals, refill scheduling, and whether adjustments to dose frequency might better suit your genetic predispositions and lifestyle. This integrated approach reinforces medication adherence and optimizes therapeutic potential.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

• Compounded Semaglutide 2
• Compounded Semaglutide
• Medvi Semaglutide
• Bioverse Semaglutide